- Niveau:
- MBO+
- Kosten:
- € 995,- Prijsinformatie
- Totale lesduur:
- 2 dagen
- Max. deelnemers:
- 12
Informatie aanvragen is helaas niet mogelijk voor deze training
U kunt een In-company offerte aanvraag doen, of alternatieven bekijken:
ISA can bring any course to your location. The expert instruction, training materials, and portable hands-on laboratories come to your facility. All you have to do is pick the time and place – ISA does the rest!
Heeft u de cursus Validation, GAMP & 21CFR11 bij ISA Europe gevolgd? Help anderen door uw ervaring te delen op Springest!
Springest doneert €1,- aan Stichting Edukans als dank voor jouw ervaring
ISA can bring any course to your location. The expert instruction, training materials, and portable hands-on laboratories come to your facility. All you have to do is pick the time and place – ISA does the rest!
Validation, GAMP and 21CFR11
Validation in the pharmaceutical (and medical device) industry is defined as the documented act of demonstrating that a procedure, process, and activity will consistently lead to the expected results. It often includes the qualification of systems and equipment. It is a requirement for Good Manufacturing Practices and other regulatory requirements.
Validation according the FDA is "Establishing documented evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting its pre-determined specifications and quality attributes." (FDA 1987). A properly designed system will provide a high degree of assurance that every step, process, and change has been properly evaluated before its implementation. Testing a sample of a final product is not considered sufficient evidence that every product within a batch meets the required specification.
Validation also concerns computerized systems. The ISPE’s guide GAMP® 5 A Risk-based Approach to Compliant GxP Computerized Systems published in February 2008 provides pragmatic and practical industry guidance to achieve compliant computerized systems fit for intended use in an efficient and effective manner.
Title 21 CFR Part 11 of the Code of Federal Regulations deals with the Food and Drug Administration (FDA) guidelines on electronic records and electronic signatures. Part 11, as it is commonly called, defines the criteria under which electronic records and electronic signatures are considered to be trustworthy, reliable and equivalent to paper records.
Purpose
Length
2 days
Course data & times
7 & 8 April 2011 (thu, fri), 9.00 - 16.30
Er zijn nog geen ervaringen. Deel je ervaring en help zo anderen kiezen. Als dank doneert Springest €1,- aan Stichting Edukans.
Je helpt hiermee anderen kiezen. Als dank doneert Springest €1,- aan Stichting Edukans.
Vergelijk 26.830 trainingen en opleidingen in Kwaliteitsmanagement
ISA Europe
€ 995,- | 2 dagen
Abonneer u op onze nieuwsbrief en ontvang maandelijks een update over persoonlijke ontwikkeling en carrièretips. Lees alle nieuwsbrieven